FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa.



from The Medical News http://www.news-medical.net/news/20141230/FDA-provides-Emergency-Use-Authorization-for-Roches-LightMix-Ebola-Zaire-rRT-PCR-Test.aspx